JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kemp, E H
Right arrow Articles by Weetman, A P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kemp, E H
Right arrow Articles by Weetman, A P
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Autoimmune Diseases
Journal of Clinical Pathology 2003;56:475-477
© 2003 BMJ Publishing Group & Association of Clinical Pathologists


SHORT REPORT

HLA-G does not have a pathophysiological role in Graves’ disease

E H Kemp, R A Metcalfe, P F Watson, A P Weetman

Division of Clinical Sciences (North), University of Sheffield, Sheffield S5 7AU UK.

Correspondence to:
Dr E H Kemp, Division of Clinical Sciences (North), University of Sheffield, Northern General Hospital, Sheffield S5 7AU, UK;
e.h.kemp{at}sheffield.ac.uk
ABSTRACT
Aims: It has been suggested that the non-classic HLA class I molecule HLA-G plays a role in autoimmune disease by protecting tissues from damage by infiltrating cytotoxic T cells. Such infiltration occurs in the thyroid of patients with Graves’ disease (GD) and Hashimoto’s thyroiditis (HT) and can eventually result in tissue destruction. The aim of the current study was to analyse thyroid tissue and thyrocytes obtained from individuals with autoimmune thyroid disease for the expression of HLA-G.

Methods: HLA-G expression was analysed in thyroid tissue taken from six patients with GD and one with HT by reverse transcriptase polymerase chain reaction. Thyroid tissue samples isolated from six patients with multinodular goitre (MNG) were used as non-autoimmune controls. HLA-G expression was also examined in cultured thyroid follicular cells (TFCs).

Results: The expression of HLA-G was not detected in the thyroid gland of patients with either GD, HT, or MNG. Furthermore, HLA-G expression could not be detected in cultured patient TFCs under basal conditions or after stimulation with the proinflammatory cytokines—interleukin 1{alpha}, interferon {gamma}, and tumour necrosis factor {alpha}.

Conclusions: HLA-G expression does not occur in the thyroid of patients with GD, indicating that HLA-G does not play a pathophysiological role in this autoimmune disorder. Although the expression of HLA-G was not detected in the thyroid sample of the patient with HT, a greater sample size would be required to conclude that HLA-G does not have a part to play in this autoimmune thyroid disease.


Keywords: autoimmunity; Graves’ disease; Hashimoto’s thyroiditis; HLA-G; thyroid follicular cell

Abbreviations: GD, Graves’ disease; HLA, human lymphocyte antigen; HT, Hashimoto’s thyroiditis; IFN{gamma}, interferon {gamma}; IL-1{alpha}, interleukin 1{alpha}; M-MLV, Moloney murine leukaemia virus; MNG, multinodular goitre; RT-PCR, reverse transcriptase polymerase chain reaction; s, soluble; TFC, thyroid follicular cell; Th, T helper; TNF{alpha}, tumour necrosis factor {alpha}; TSH, thyroid stimulating hormone







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2003 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.